Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-02-11 @ 12:39 AM
Study NCT ID:
NCT02616250
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2015-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2016-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-24
First Submit QC Date:
None
Study First Post Date:
2015-11-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-19
Results First Submit QC Date:
None
Results First Post Date:
2017-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-16
Last Update Post Date:
2021-02-18
Last Update Post Date Type:
ACTUAL